490646815	490646815	CD	B-NP	O
|	|	NNP	I-NP	O
JC	JC	NNP	I-NP	O
|	|	VBD	B-VP	O
31530471	31530471	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4448830	4448830	CD	B-NP	O
|	|	CC	I-NP	O
10/6/2007	10/6/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ABDOMINAL	ABDOMINAL	NNP	I-NP	I-protein
PAIN	PAIN	NNP	I-NP	I-protein
;	;	:	O	O
RENAL	RENAL	NNP	B-NP	O
FAILURE	FAILURE	NNP	I-NP	O
,	,	,	O	O
PULIMONARY	PULIMONARY	NNP	B-NP	O
EDEMA	EDEMA	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/19/2007	10/19/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/18/2007	1/18/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
ARBOLEDA	ARBOLEDA	NNP	B-NP	O
,	,	,	O	O
CORNELL	CORNELL	NNP	B-NP	O
MD	MD	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Abdominal	Abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Pneumonia	Pneumonia	NNP	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
86-year-old	86-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
past	past	JJ	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
and	and	CC	O	O
tricuspid	tricuspid	JJ	B-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
prior	prior	JJ	B-NP	O
small-bowel	small-bowel	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
and	and	CC	I-NP	O
GI	GI	NN	I-NP	O
bleeding	bleeding	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
sudden	sudden	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
became	become	VBD	B-VP	O
progressively	progressively	RB	B-ADJP	O
worse	worse	JJR	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
green/yellow	green/yellow	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
suspected	suspect	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
aspiration	aspiration	NN	I-NP	O
event	event	NN	I-NP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
fever	fever	NN	B-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
dysuria	dysuria	NNS	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
sick	sick	JJ	I-NP	O
contacts	contact	NNS	I-NP	O
.	.	.	O	O

EMERGENCY	EMERGENCY	NN	B-NP	O
DEPARTMENT	DEPARTMENT	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
97.5	97.5	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
74	74	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
183/65	183/65	CD	I-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
128/56	128/56	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
subsequently	subsequently	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
to	to	TO	B-PP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	O	O
improved	improve	VBN	B-VP	O
to	to	TO	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
positive	positive	JJ	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distension	distension	NN	I-NP	O
,	,	,	O	O
3/6	3/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
,	,	,	O	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
quadrant	quadrant	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
,	,	,	O	O
abdomen	abdomen	NN	B-NP	O
soft	soft	JJ	I-NP	O
and	and	CC	O	O
without	without	IN	B-PP	O
rebound	rebound	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
KUB	KUB	NN	I-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
obstruction	obstruction	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
mild	mild	JJ	B-NP	O
diffuse	diffuse	JJ	I-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
thickening	thicken	VBG	B-VP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
versus	versus	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
,	,	,	O	O
azithromycin	azithromycin	NN	B-NP	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x1	x1	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
bioprosthetic	bioprosthetic	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
and	and	CC	O	O
tricuspid	tricuspid	JJ	B-NP	B-protein
valve	valve	NN	I-NP	I-protein
repair	repair	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
2000	2000	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
=	=	SYM	B-VP	O
2.6	2.6	CD	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
small-bowel	small-bowel	JJ	B-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
No-jack	No-jack	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
admission	admission	NN	I-NP	O
in	in	IN	B-PP	O
7/8	7/8	CD	B-NP	O
with	with	IN	B-PP	O
capsule	capsule	NN	B-NP	O
study	study	NN	I-NP	O
demonstrating	demonstrate	VBG	B-VP	O
small	small	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
lymphangiectasias	lymphangiectasia	NNS	I-NP	O
and	and	CC	I-NP	O
angiectasis	angiectasis	NN	I-NP	O
,	,	,	O	O
colonoscopy	colonoscopy	NN	B-NP	O
demonstrating	demonstrate	VBG	B-VP	O
sessile	sessile	NN	B-NP	O
polyps	polyp	NNS	I-NP	O
and	and	CC	O	O
diverticulitis	diverticulitis	NN	B-NP	O
,	,	,	O	O
questionable	questionable	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
mesenteric	mesenteric	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
right	right	JJ	B-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CVA	CVA	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
55	55	CD	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Renagel	Renagel	NNP	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
with	with	IN	B-PP	O
dinner	dinner	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diovan	Diovan	NNP	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Procrit	Procrit	NN	B-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Norvasc	Norvasc	RB	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Norvasc	Norvasc	RB	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Imdur	Imdur	IN	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NNP	B-NP	O
4/4/5	4/4/5	CD	I-NP	O
plus	plus	CC	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
8	8	CD	I-NP	O
units	unit	NNS	I-NP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Caltrate	Caltrate	NN	B-NP	O
plus	plus	CC	I-NP	O
D	D	NN	I-NP	O
one	one	CD	B-NP	O
tab	tab	NN	I-NP	B-protein
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
plus	plus	CC	O	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
Codeine	Codeine	NN	B-NP	O
and	and	CC	I-NP	O
Benadryl	Benadryl	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
96.6	96.6	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
62	62	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
108/60	108/60	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
l.	l.	NN	I-NP	O
Chest	Chest	NNP	B-NP	O
with	with	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
dullness	dullness	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
basilar	basilar	JJ	I-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
egophony	egophony	NN	I-NP	O
at	at	IN	B-PP	O
right	right	JJ	B-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
3/6	3/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
mid	mid	NN	I-NP	O
peaking	peak	VBG	B-VP	O
murmur	murmur	NN	B-NP	O
at	at	IN	B-PP	O
left	left	JJ	B-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
heard	hear	VBD	B-VP	O
throughout	throughout	IN	B-PRT	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Guaiac	Guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
141	141	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.5	4.5	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
101	101	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-cell_line
111	111	CD	I-NP	I-cell_line
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
2.7	2.7	CD	I-NP	I-protein
and	and	CC	O	O
glucose	glucose	NN	B-NP	B-protein
206	206	CD	I-NP	I-protein
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
6.29	6.29	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
37.7	37.7	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
38.5	38.5	CD	I-NP	O
at	at	IN	B-PP	O
last	last	JJ	B-NP	B-protein
check	check	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
260	260	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
2.8	2.8	CD	I-NP	I-protein
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
amylase	amylase	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
,	,	,	O	O
lipase	lipase	NN	B-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
3.7	3.7	CD	I-NP	I-protein
,	,	,	O	O
lactate	lactate	NN	B-NP	O
1.7	1.7	CD	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
+	+	SYM	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
RBC	RBC	NN	B-NP	B-protein
0	0	CD	I-NP	I-protein
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/12/07	2/12/07	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Cardiomegaly	Cardiomegaly	NNP	B-NP	O
,	,	,	O	O
mediastinal	mediastinal	JJ	B-NP	O
wires	wire	NNS	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
cephalization	cephalization	NN	I-NP	O
and	and	CC	O	O
Kerley	Kerley	NNP	B-NP	O
B	B	NN	I-NP	O
lines	line	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
opacification	opacification	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

KUB	KUB	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
2/12/07	2/12/07	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-ADJP	O
:	:	:	O	O
Nonspecific	Nonspecific	JJ	B-NP	O
gas	gas	NN	I-NP	O
pattern	pattern	NN	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
obstruction	obstruction	NN	B-NP	O
or	or	CC	O	O
free	free	JJ	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Calcified	Calcify	VBN	B-NP	O
aorta	aorta	NN	I-NP	O
and	and	CC	I-NP	O
iliac	iliac	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CT	CT	NN	B-NP	O
abdomen	abdoman	NNS	I-NP	O
-LRB-	-LRB-	SYM	B-ADJP	O
1/14/070	1/14/070	CD	B-NP	O
:	:	:	O	O
1bilateral	1bilateral	JJ	B-NP	O
infiltrates	infiltrate	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
questionable	questionable	JJ	B-NP	O
mild	mild	JJ	I-NP	O
diffuse	diffuse	JJ	I-NP	O
small-bowel	small-bowel	JJ	I-NP	O
thickening	thickening	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
appendicitis	appendicitis	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
perforation	perforation	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
gallstones	gallstone	NNS	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
distension	distension	NN	I-NP	O
without	without	IN	B-PP	O
wall	wall	NN	B-NP	O
thickening	thickening	NN	I-NP	O
or	or	CC	O	O
pericholecystic	pericholecystic	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
2/12/07	2/12/07	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-ADJP	O
:	:	:	O	O
Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
at	at	IN	B-PP	O
71	71	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
pseudonormalized	pseudonormalize	VBD	B-VP	O
.	.	.	O	O

CONSULTING	CONSULTING	NN	B-NP	O
SERVICES	SERVICES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Gastroenterology	Gastroenterology	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Surgery	Surgery	NNP	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
:	:	:	O	O
Unclear	Unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
mesenteric	mesenteric	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
and	and	CC	O	O
questionable	questionable	JJ	B-NP	O
small-bowel	small-bowel	NN	I-NP	O
thickening	thicken	VBG	B-VP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
concern	concern	NN	I-NP	O
GI	GI	NN	I-NP	O
and	and	CC	O	O
Surgical	Surgical	JJ	B-NP	O
Services	Service	NNS	I-NP	O
were	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
followed	follow	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
over	over	IN	B-PP	O
Hospital	Hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Serial	Serial	JJ	B-NP	O
CBC	CBC	NN	I-NP	O
,	,	,	I-NP	O
lactate	lactate	NN	I-NP	O
and	and	CC	I-NP	O
anion	anion	NN	I-NP	O
gaps	gap	NNS	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
had	have	VBD	B-VP	O
fully	fully	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
on	on	IN	B-PP	O
clears	clear	NNS	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
most	most	RBS	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
viral	viral	JJ	B-NP	O
enteritis	enteritis	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
,	,	,	O	O
further	further	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
vessels	vessel	NNS	I-NP	O
by	by	IN	B-PP	O
MRA	MRA	NN	B-NP	B-protein
during	during	IN	B-PP	O
followup	followup	NN	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
GI	GI	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pneumonia	Pneumonia	NN	B-NP	O
:	:	:	O	O
Bilateral	Bilateral	JJ	B-NP	O
infiltrates	infiltrate	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
empirically	empirically	RB	B-ADVP	O
with	with	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
,	,	,	O	O
azithromycin	azithromycin	NN	B-NP	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
cefpodoxime	cefpodoxime	NN	B-NP	O
plus	plus	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
febrile	febrile	JJ	B-ADJP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
#	#	#	I-NP	I-protein
4	4	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
3/7/07	3/7/07	CD	I-NP	O
-RRB-	-RRB-	HYPH	O	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
101.9	101.9	CD	I-NP	O
and	and	CC	O	O
as	as	IN	B-PP	O
such	such	JJ	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
and	and	CC	O	O
azithromycin	azithromycin	NN	B-NP	O
IV	IV	CD	I-NP	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
10/25/07	10/25/07	CD	B-NP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
six	six	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
cefpodoxime	cefpodoxime	NN	B-NP	O
,	,	,	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
lactobacillus	lactobacillus	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
probiotic	probiotic	JJ	I-NP	O
agent	agent	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypoxemia	Hypoxemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hypoxemia	hypoxemia	NN	I-NP	O
included	include	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
Hospital	Hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
room	room	NN	I-NP	O
air	air	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
95-97	95-97	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mildly	mildly	RB	B-ADJP	O
hypervolemic	hypervolemic	JJ	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
gently	gently	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
room	room	NN	I-NP	O
air	air	NN	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
gentle	gentle	JJ	B-NP	O
oral	oral	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	I-NP	O
VNA	VNA	NN	I-NP	O
services	service	NNS	I-NP	O
were	be	VBD	B-VP	O
arranged	arrange	VBN	I-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
and	and	CC	O	O
daily	daily	JJ	B-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
33-36	33-36	CD	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	JJ	B-ADJP	O
negative	negative	JJ	I-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
active	active	JJ	I-NP	O
type	type	NN	I-NP	O
and	and	CC	I-NP	O
screen	screen	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleeding	bleed	VBG	B-VP	O
throughout	throughout	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
37.7	37.7	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
33.5	33.5	CD	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
weekly	weekly	JJ	I-NP	O
Procrit	Procrit	NNP	I-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
injection	injection	NN	I-NP	O
on	on	IN	B-PP	O
10/25/07	10/25/07	CD	B-NP	O
prior	prior	JJ	I-NP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
resume	resume	VB	I-VP	O
iron	iron	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
admission	admission	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
elevated	elevate	VBN	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
versus	versus	IN	B-PP	O
insufficient	insufficient	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
gently	gently	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
57	57	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
weight	weight	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
61	61	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
still	still	RB	B-ADVP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
and	and	CC	O	O
interstitial	interstitial	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
still	still	RB	B-ADJP	O
mildly	mildly	RB	I-ADJP	O
hypervolemic	hypervolemic	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
gentle	gentle	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
increase	increase	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
measure	measure	VB	I-VP	O
her	her	PRP$	B-NP	O
weights	weight	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Michele	Michele	NNP	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
titration	titration	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
diuretic	diuretic	JJ	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
183/65	183/65	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
improved	improve	VBN	B-VP	O
over	over	IN	B-PP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
110-120s	110-120s	CD	I-NP	O
/	/	SYM	I-NP	O
60s-70s	60s-70	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
slightly	slightly	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
from	from	IN	B-PP	O
130s-150s	130s-150s	CD	B-NP	O
/	/	SYM	I-NP	O
70s	70s	CD	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
valsartan	valsartan	NN	I-NP	O
and	and	CC	I-NP	O
Norvasc	Norvasc	NN	I-NP	O
were	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Imdur	Imdur	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
remained	remain	VBD	B-VP	O
well	well	RB	B-ADJP	O
controlled	control	VBN	I-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
100-122/46	100-122/46	CD	B-NP	O
-71	-71	CD	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
:	:	:	O	O
With	With	IN	B-PP	O
pseudoregularization	pseudoregularization	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
supratherapeutic	supratherapeutic	JJ	I-NP	O
INR	INR	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
concurrent	concurrent	JJ	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
2.1	2.1	CD	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
4	4	CD	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
2.7	2.7	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
while	while	IN	B-SBAR	O
still	still	RB	B-ADVP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
Services	Service	NNS	I-NP	O
were	be	VBD	B-VP	O
arranged	arrange	VBN	I-VP	O
to	to	TO	I-VP	O
measure	measure	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
on	on	IN	B-PP	O
7/11/07	7/11/07	CD	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
send	send	VB	I-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
WSMH	WSMH	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
,	,	,	O	O
915-360-5305	915-360-5305	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
2.7	2.7	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
slightly	slightly	RB	B-VP	O
increased	increase	VBD	I-VP	O
creatinine	creatinine	NN	B-NP	O
to	to	TO	B-PP	O
3.2	3.2	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
BUN	BUN	NN	I-NP	O
was	be	VBD	B-VP	O
83	83	CD	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
111	111	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
contraction	contraction	NN	B-NP	O
alkalosis	alkalosis	NN	I-NP	O
with	with	IN	B-PP	O
bicarbonate	bicarbonate	NN	B-NP	O
=	=	SYM	B-VP	O
22	22	CD	B-NP	O
on	on	IN	B-PP	O
a.m.	a.m.	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
BUN	BUN	NN	I-NP	O
,	,	,	I-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	I-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
rechecked	rechecke	VBN	I-VP	O
on	on	IN	B-PP	O
7/11/07	7/11/07	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
Dr	Dr	NNP	B-NP	O
Banana	Banana	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Bechman	Bechman	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
nephrology	nephrology	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
titration	titration	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
Lantus	Lantus	NNP	I-NP	O
and	and	CC	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

Standing	Stand	VBG	B-VP	O
NovoLog	NovoLog	NNP	B-NP	O
insulin	insulin	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
was	be	VBD	B-VP	O
reinitiated	reinitiate	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lantus	Lantus	NNP	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
glucose	glucose	NN	B-NP	O
control	control	NN	I-NP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
at	at	IN	B-PP	O
increased	increase	VBN	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
8	8	CD	I-NP	O
units	unit	NNS	I-NP	O
nightly	nightly	RB	B-ADVP	O
plus	plus	CC	O	O
NovoLog	NovoLog	NN	B-NP	B-protein
4	4	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
with	with	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
lunch	lunch	NN	B-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
dinner	dinner	NN	B-NP	O
plus	plus	CC	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

PROPHYLAXIS	PROPHYLAXIS	NN	B-NP	O
:	:	:	O	O
TEDs/Coumadin	TEDs/Coumadin	NN	B-NP	O
,	,	,	O	O
PPI	PPI	NN	B-NP	B-protein
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

CONTACT	CONTACT	NN	B-NP	O
:	:	:	O	O
Florencio	Florencio	NNP	B-NP	O
Kisto	Kisto	NNP	I-NP	O
,	,	,	O	O
daughter/healthcare	daughter/healthcare	NN	B-NP	O
proxy	proxy	NN	I-NP	O
,	,	,	O	O
cell	cell	NN	B-NP	O
554-019-1437	554-019-1437	CD	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
181-009-9482	181-009-9482	CD	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
65	65	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
122/46	122/46	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
room	room	NN	I-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
Breathing	Breathing	NNP	B-NP	O
comfortably	comfortably	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Bilateral	Bilateral	JJ	B-NP	O
BASILAR	BASILAR	NN	I-NP	O
Rales	Rale	NNS	I-NP	O
right	right	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
3/6	3/6	CD	B-NP	O
mid	mid	JJ	I-NP	O
peaking	peak	VBG	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
left	left	JJ	B-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
heard	hear	VBD	B-VP	O
throughout	throughout	IN	B-ADVP	O
,	,	,	O	O
external	external	JJ	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
,	,	,	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Trace	Trace	NN	B-NP	O
bilateral	bilateral	JJ	I-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
pigmentation	pigmentation	NN	I-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
shins	shin	NNS	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Norvasc	Norvasc	RB	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Norvasc	Norvasc	RB	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Azithromycin	Azithromycin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
x6	x6	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Caltrate	Caltrate	NNP	B-NP	O
600	600	CD	I-NP	O
plus	plus	CC	O	O
D	D	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Cefpodoxime	Cefpodoxime	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
x6	x6	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-NP	O
,	,	,	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Procrit	Procrit	NN	B-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Ferrous	Ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
4	4	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
with	with	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
lunch	lunch	NN	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
dinner	dinner	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
,	,	,	O	O
glargine	glargine	NN	B-NP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Isosorbide	Isosorbide	NN	B-NP	O
mononitrate	mononitrate	NN	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Lactobacillus	Lactobacillus	NN	B-NP	O
two	two	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	RB	B-NP	O
three	three	CD	I-NP	O
times	time	NNS	I-NP	O
daily	daily	JJ	I-NP	O
x25	x25	CD	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
8	8	CD	I-NP	O
h.	h.	NN	I-NP	O
x19	x19	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Sevelamer	Sevelamer	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

Diovan	Diovan	NNP	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
levels	level	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
HCVMC	HCVMC	NNP	I-NP	B-cell_type
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-6573465	7-6573465	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MILANI	MILANI	NNP	B-NP	O
,	,	,	O	O
HARLAND	HARLAND	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NALDER	NALDER	NNP	B-NP	O
,	,	,	O	O
MATHEW	MATHEW	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3700972	3700972	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/9/07	11/9/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/9/07	11/9/07	CD	B-NP	O

